(Q40269264)
Statements
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024) (English)
R Pat Bucy
Donna Mildvan
Jorge Santana-Bagur
Jeff Lennox
Chris Pilcher
Andrew Zolopa
Jody Lawrence
Richard B Pollard
Raphaelle El Habib
David Sahner
Lawrence Fox
Evgenia Aga
Ronald J Bosch
Ronald Mitsuyasu
Adult AIDS Clinical Trials Group A5024 Protocol Team
8 November 2006